Production (Stage)
Pharming Group N.V.
PHGUF
$1.19
$0.18518.50%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -- | 18.84% | -440.75% | -177.14% | |
| Total Depreciation and Amortization | -- | 10.64% | 67.42% | 25.14% | |
| Total Amortization of Deferred Charges | -- | 22.78% | 22.78% | 22.78% | |
| Total Other Non-Cash Items | -- | 437.95% | 71.45% | -322.78% | |
| Change in Net Operating Assets | -- | -269.77% | 19.10% | -4,282.69% | |
| Cash from Operations | -- | 60.40% | -131.20% | -177.04% | |
| Capital Expenditure | -- | 54.38% | 5.86% | -4.43% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 63.31% | -1,952.98% | -2,010.29% | |
| Cash from Investing | -- | 63.09% | -2,444.20% | -2,531.19% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -3,117.24% | 8.54% | -13.80% | |
| Issuance of Common Stock | -- | 359.21% | 227.35% | 316.22% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -24.10% | -65.02% | -53.59% | |
| Cash from Financing | -- | -284.80% | 81.37% | 79.14% | |
| Foreign Exchange rate Adjustments | -- | -110.92% | 71.68% | 128.82% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 31.85% | -2,615.35% | -1,044.36% | |